Core Insights - The presentation titled "The New Frontier of Longevity Science: Living Well Beyond Your Years" will be led by Dr. Jeffrey A. Lieberman and Dr. David A. Sinclair, focusing on advances in longevity science and the potential to extend human lifespan beyond 100 years while maintaining quality of life [2][3] Group 1: Presentation Details - The event will take place on March 10, 2025, from 2:30 p.m. to 3:30 p.m. at the JW Marriott Austin as part of SXSW 2025's Health & MedTech Track [3] - Following the presentation, Dr. Lieberman will sign copies of his book "Malady of the Mind: Schizophrenia and the Path to Prevention" at the SXSW Bookstore [4] Group 2: Speakers' Backgrounds - Dr. Jeffrey A. Lieberman is a clinical neuroscientist and psychiatrist known for his research on brain disorders and mental illness, with over 800 scientific articles published and cited more than 100,000 times [5] - Dr. David A. Sinclair is a Professor of Genetics at Harvard Medical School, recognized for his research on aging and age-related diseases, with over 180 peer-reviewed articles published and cited over 97,000 times [6][8] Group 3: Key Topics of Discussion - The presentation will cover pivotal advancements in medicine, including human genome sequencing and the discovery of Sirtuin genes, which have made altering the aging process scientifically plausible [7] - It will also discuss holistic strategies and pharmaceutical therapies aimed at enhancing health and targeting aging at the cellular level [7] - Enhanced therapeutic strategies for brain longevity will be explored, including techniques like transcranial magnetic stimulation and psychedelics [7]

ANI Pharmaceuticals (ANIP) Q4 2024 Earnings Call February 28, 2025 08:00 AM ET Company Participants Lisa Wilson - Founder and PresidentNikhil Lalwani - President and CEOChristopher Mutz - Senior Vp & Head of Rare DiseaseStephen Carey - Senior VP of Finance & CFOGary Nachman - Managing Director - Equity ResearchJeevan Larson - Equity Research AssociateGlen Santangelo - Managing Director Conference Call Participants David Amsellem - Sr. Research AnalystVamil Divan - Managing Director & Senior Research Analyst ...

ANI Pharmaceuticals (ANIP) Q4 2024 Earnings Call February 28, 2025 08:00 AM ET Company Participants Lisa Wilson - Founder and PresidentNikhil Lalwani - President and CEOChristopher Mutz - Senior Vp & Head of Rare DiseaseStephen Carey - Senior VP of Finance & CFOGary Nachman - Managing Director - Equity ResearchJeevan Larson - Equity Research AssociateGlen Santangelo - Managing Director Conference Call Participants David Amsellem - Sr. Research AnalystVamil Divan - Managing Director & Senior Research Analyst ...

Flowers Foods (FLO) Q4 2024 Earnings Call February 07, 2025 08:30 AM ET Company Participants J.T. Rieck - Vice President of Investor Relations and TreasurerRyals McMullian - Chairman & CEOSteve Kinsey - CFOBill Chappell - Managing DirectorRob Dickerson - Managing Director - Consumer Staples Equity ResearchMitchell Pinheiro - DirectorMax Gumport - Director - Equity Research Conference Call Participants Steve Powers - Equity Research AnalystJim Salera - Research AnalystBrian Holland - MD - Research Analyst Op ...

Roivant Overview J.P. Morgan Healthcare Conference January 9, 2023 Forward-Looking Statements Forward–Looking Statements This presentation includes forward-looking statements that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, ...